S. McAuley

Cutaneous T-cell lymphoma (CTCL) responses to a TLR9 agonist CPG immunomodulator (CPG 7909), a phase I study

Youn H. Kim, M. Girardi, T. Schmalbach, 2004 .

Cutaneous T-cell lymphoma (CTCL) responses to a TLR9 agonist CPG immunomodulator (CPG 7909), a phase I study.

M. Girardi, T. Schmalbach, Y. Kim, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.